Fidelity Investments’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Fidelity Investments’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,105,411	Closed	-$123M	–	2892
2014 Q2	$123M	Buy	5,105,411 +4,732,828	+1,270%	+$49.3M	0.02%	890
2014 Q1	$2.25M	Hold	372,583	–	–	﹤0.01%	2364
2013 Q4	$2.23M	Sell	372,583 -1,440,300	-79%	-$6.66M	﹤0.01%	2332
2013 Q3	$9.45M	Sell	1,812,883 -477,800	-21%	-$2.09M	﹤0.01%	1960
2013 Q2	$8.27M	Buy	+2,290,683	New	+$9.37M	﹤0.01%	1989

Fidelity Investments's IDIX Position: Q3 2014 in Review

Fidelity Investments sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 5,105,411 shares — an estimated $123M sold.

Fidelity Investments first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $123M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Fidelity Investments reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Fidelity Investments sold 5,105,411 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $123M.
Fidelity Investments first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Fidelity Investments's IDENIX PHARMACEUTICALS INC position peaked at $123M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Fidelity Investments's 13F filing for Q3 2014, filed 14 Nov 2014.